Please check your internet connection and try again.
# Megacv Duo
## Overview
Megacv Duo is a combination antibiotic containing **Amoxicillin** (a beta-lactam) and **Clavulanate Potassium** (a beta-lactamase inhibitor). It is used to overcome resistance in bacteria that produce beta-lactamase enzymes.
## Primary Indications
* Community-acquired pneumonia
* Acute bacterial sinusitis
* Acute otitis media
* Skin and skin structure infections
* Urinary tract infections
## Adult Dosing
Standard dosing is based on the amoxicillin component:
* **Mild-to-moderate infection:** 500 mg amoxicillin/125 mg clavulanate every 8 to 12 hours.
* **Severe infection/Respiratory tract:** 875 mg amoxicillin/125 mg clavulanate every 12 hours.
* **Maximum:** Do not exceed 875 mg amoxicillin per dose.
## Pediatric Dosing
Dosing is based on the amoxicillin component and weight (typically 20–45 mg/kg/day divided every 8 to 12 hours depending on infection severity):
* **Acute Otitis Media/Pneumonia:** 80–90 mg/kg/day divided every 12 hours (using the 7:1 ratio suspension).
* **Note:** Always verify the specific concentration of the suspension provided as versions vary significantly.
## Dose Adjustments
* **Renal Impairment:** Reduce dose or increase interval if CrCl < 30 mL/min.
* **Note:** Extended-release formulations (e.g., 1000 mg/62.5 mg) should **not** be used in patients with severe renal impairment (CrCl < 30 mL/min).
## Contraindications
* Hypersensitivity to amoxicillin, clavulanate, or any penicillin.
* History of cholestatic jaundice or hepatic dysfunction associated with previous use of amoxicillin/clavulanate.
## Adverse Effects
* **Gastrointestinal:** Diarrhea (very common), nausea, vomiting, abdominal pain.
* **Hepatic:** Transaminase elevation, cholestatic jaundice (more common in men and the elderly).
* **Hypersensitivity:** Rash, urticaria, anaphylaxis (rare).
* **Other:** Candidiasis (oral or vaginal).
## Key Drug Interactions
* **Warfarin:** May increase INR and risk of bleeding.
* **Methotrexate:** May increase serum levels and toxicity.
* **Oral Contraceptives:** Potential decrease in efficacy (use backup contraception).
* **Probenecid:** Decreases renal excretion of amoxicillin, increasing serum levels.
## Monitoring
* Renal and hepatic function (especially during prolonged therapy).
* Signs of hypersensitivity (rash, anaphylaxis).
* Resolution of infection symptoms.
* Signs of *Clostridioides difficile*-associated diarrhea.
## Clinical Pearls
* **Administration:** Take with food to minimize GI upset and improve absorption.
* **Stability:** Once reconstituted, oral suspensions must be refrigerated and discarded after 10 days.
* **Clavulanate content:** Do not use the 250 mg tablet formulation (or multiples) for 875 mg dosing to avoid reaching supratherapeutic levels of clavulanate, which may cause GI distress.
* **Dosing protocol:** Specific local antibiograms and institutional protocols for empiric therapy should be consulted prior to prescribing.
***
**Educational Disclaimer:** This information is for educational purposes only. Always verify drug doses, contraindications, and patient-specific factors against current clinical guidelines, institutional protocols, and the manufacturer’s official prescribing information before prescribing or administering medication.
